Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb:79:275-280.
doi: 10.1016/j.ijscr.2021.01.031. Epub 2021 Jan 15.

Recurrent squamous cell carcinoma in a post cardiac transplant patient

Anushka S Ruwanpathirana  1 , Samantha J Fernando  2 , M Vinati Molligoda  3 , Jay G Fernando  4 , Wayne W Zhang  5 , Shyamal Premaratne  6
Affiliations
Case Reports

Recurrent squamous cell carcinoma in a post cardiac transplant patient

Anushka S Ruwanpathirana et al. Int J Surg Case Rep. 2021 Feb.

Abstract

Introduction and importance: Solid organ transplantation has evolved along with dramatic advancements in definitive treatment for irreversible and uncompensated organ failure. Transplanted organ survival has improved as a result of reduced allograft rejection. However, negative long-term outcomes which were largely due to the adverse effects of rapidly evolving immunosuppressive regimens are still evident. The emergence of malignancies following prolonged exposure to immunosuppression treatment has affected the quality of life in transplant recipients. They are approximately one hundred times more likely to develop squamous cell carcinoma (SCC) compared to the general population and the incidence of malignant melanomas, basal cell carcinomas, and Kaposi's sarcomas are also on the rise. The incidence of de novo malignancies ranges from 9 to 21% and is commonly seen in the skin and the lymphoreticular system in these patients.

Case presentation: A 78-year-old male presented with a lump in the right axilla, which had grown in size over a 4-week period. Patient had received a cardiac transplant 9 years prior and was on a regimen of Tacrolimus and Mycophenolate Mofetil since then.

Clinical discussion: Following 4 years of immunosuppression therapy, the patient developed a non-healing ulcer on his right forearm and the biopsy confirmed SCC. The recent biopsy performed on the new axillary lump also confirmed SCC. Iatrogenic immune suppressive treatment is associated with the occurrence of de novo, non-melanoma skin cancers in the solid organ transplant recipients and this necessitates early and comprehensive cancer surveillance models to be included in the pre and post-transplant assessment.

Conclusion: Advances in immunology suggest that peripheral blood mononuclear cell sequencing and immune profiling to identify immune phenotypes associated with keratinocyte cancers allow us to recognize patients who are more susceptible for SCC following organ transplantation and immunosuppression.

Keywords: Cancer; Heart transplantation; Immunosuppression; Squamous cell carcinoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Swollen right hand compared with the left hand.
Fig. 2
Fig. 2
Lump in the right axilla measuring 2″ X 2″.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Khush K.K., Cherikh W.S., Chambers D.C. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult heart transplantation report-2018; focus theme: multiorgan transplantation. J. Heart Lung Transplant. 2018;37(10):1155–1168. - PubMed
    1. Karen S., Peter Z. 50th anniversary of the first human heart transplant how is it seen today? Eur. Heart J. 2017;38(46):3402–3404. - PubMed
    1. Rodriguez C.B.H., Sündermann S.H., Emmert M.Y. Surviving 20 years after heart transplantation: a success story. Ann. Thorac. Surg. 2014;97:499–504. - PubMed
    1. Ajithkumar T.V., Parkinson C.A., Butler A., Hatcher H.M. Management of solid tumors in organ-transplant recipients. Lancet Oncol. 2007;8(10):921–932. - PubMed
    1. Yagdi T., Sharples L., Tsui S., Large S., Parameshwar J. Malignancy after heart transplantation: analysis of 24-year experience at a single center. J. Card. Surg. 2009;24(5):572–579. - PubMed

Publication types